AQR CAPITAL MANAGEMENT LLC
Position in IOVA — Iovance Biotherapeutics, Inc.
CIK 1167557
Greenwich, CT
Position in IOVA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,190,826
+$1,888,915 QoQ
Shares Held
624,168
+464.4% QoQ
Ownership
0.140%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
15 quarters on record
Voting authority
Sole 99.99086784327297.ToString("F0")%
Shared 0.ToString("F0")%
None 0.009132156727035028.ToString("F0")%
Common Shares in IOVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $4,606,751,734 across 214 Biotechnology names. IOVA ranks #89 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,231,008 | $951,126,014 | |
| 2 | EXEL |
Exelixis, Inc.
|
13,095,741 | $561,676,326 | |
| 3 | INCY |
Incyte Corp
|
5,807,930 | $546,642,368 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
7,676,541 | $433,647,798 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
913,104 | $302,118,715 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,338,458 | $253,035,481 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,782,038 | $181,424,357 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,946,858 | $164,727,963 |
All Filings in IOVA
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,190,826 | 624,168 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $301,911 | 110,591 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $220,031 | 101,398 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $398,448 | 231,657 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $198,265 | 59,540 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $116,260 | 15,711 | Shares | Other | 2025-02-14 | |
| 2024-06-30 | $92,045 | 11,477 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $592,963 | 40,011 | Shares | Defined | 2024-05-15 | |
| 2023-03-31 | $515,225 | 84,325 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $317,896 | 49,749 | Shares | Defined | 2023-02-14 | |
| 2021-03-31 | $1,077,136 | 34,022 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,814,193 | 39,099 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,001,097 | 30,410 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $3,011,319 | 109,702 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $2,012,357 | 67,213 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||